SEC Form 3 · accession 0000899243-18-008638
Q32 Bio Inc. · QTTB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert Seymour
Officer — Chief Scientific Officer
Period of report
Mar 27, 2018
Accepted (ET)
Mar 27, 2018 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 228,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $6.64 | holding | — | — | — | — | Dec 7, 2027 | Common Stock | 76,417 | — | D |
Explanation of responses
- F1The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018.
Remarks
Exhibit 24 - Power of Attorney.